A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells

Cytotechnology

Volumn 64, Issue 5, 2012, Pages 523-540

  Bakhshandeh, Behnaz ^a,b   Soleimani, Masoud ^c   Hafizi, Maryam ^b   Ghaemi, Nasser ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Mesenchymal stromal cells; MicroRNA; Nonviral transfection; Plasmid; USSC

Indexed keywords

LIPOFECTAMINE; MICRORNA; PLASMID DNA;

ARTICLE; CELL BASED GENE THERAPY; CELL COUNT; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MODIFICATION; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NONVIRAL GENE DELIVERY SYSTEM; TRANSIENT TRANSFECTION;

EID: 84868461950     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-012-9430-9     Document Type: Article

References (55)

1. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822. doi:10.1182/blood-2004- 04-1559.
2. Akimov IA, Kabilova TO, Vlassov VV, Chernolovskaya EL (2009) Inhibition of human cancer-cell proliferation by long double-stranded RNAs. Oligonucleotides 19:31-40. doi:10.1089/oli.2008.0151.
3. Andre F, Mir LM (2004) DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 11(Suppl 1):S33-S42. doi:10.1038/sj.gt.3302367.
4. Bakhshandeh B, Soleimani M, Ghaemi N, Shabani I (2011) Effective combination of aligned nanocomposite nanofibers and human unrestricted somatic stem cells for bone tissue engineering. Acta Pharmacol Sin 32:626-636. doi: 10.1038/aps.2011.8.
5. Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC (2006) Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12:3007-3019. doi:10.1089/ten. 2006.12.3007.
6. Brandner S (2010) Nanog, Gli, and p53: a new network of stemness in development and cancer. EMBO J 29:2475-2476. doi:10.1038/emboj.2010.162.
7. Chitwood DH, Timmermans MC (2010) Small RNAs are on the move. Nature 467:415-419. doi:10.1038/nature09351.
8. Coutant F, Frenkiel MP, Despres P, Charneau P (2008) Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine. PLoS One 3:e3973. doi: 10.1371/journal.pone.0003973.
9. Davidson BL, McCray PB Jr (2011) Current prospects for RNA interference-based therapies. Nat Rev Genet 12:329-340. doi:10.1038/nrg2968.
10. Dincer S, Turk M, Piskin E (2005) Intelligent polymers as nonviral vectors. Gene Ther 12(Suppl 1):S139-S145. doi: 10.1038/sj.gt.3302628.
11. Dinser R, Kreppel F, Zaucke F, Blank C, Paulsson M, Kochanek S, Maurer P (2001) Comparison of longterm transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochem Cell Biol 116:69-77.
12. Djuranovic S, Nahvi A, Green R (2011) A parsimonious model for gene regulation by miRNAs. Science 331:550-553. doi: 10.1126/science.1191138.
13. Falk A, Holmstrom N, Carlen M, Cassidy R, Lundberg C, Frisen J (2002) Gene delivery to adult neural stem cells. Exp Cell Res 279:34-39.
14. Feng Y, Sun Y, Jia W, Zhang C (2010) Platelet-rich plasma and 1, 25(OH)2 vitamin D3 synergistically stimulate osteogenic differentiation of adult human mesenchymal stem cells. Biotechnol Lett 32:635-642. doi:10.1007/s10529- 009-0198-8.
15. Ferguson C, Larochelle A, Dunbar CE (2005) Hematopoietic stem cell gene therapy: dead or alive? Trends Biotechnol 23:589-597. doi:10.1016/j.tibtech. 2005.09.005.
16. Gheisari Y, Soleimani M, Azadmanesh K, Zeinali S (2008) Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy 10:815-823. doi:10.1080/14653240 802474307.
17. Gonzalez G, Pfannes L, Brazas R, Striker R (2007) Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNA. J Virol Methods 145:14-21. doi:10.1016/j.jviromet.2007.04.013.
18. Hoelters J, Ciccarella M, Drechsel M, Geissler C, Gulkan H, Bocker W, Schieker M, Jochum M, Neth P (2005) Nonviral geneticmodificationmediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med 7:718-728. doi:10.1002/jgm.731.
19. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301. doi:10.1634/stemcells.2005-0342.
20. Kogler G, SenskenS, AireyJA, Trapp T, MuschenM, FeldhahnN, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, CollettiEJ, Almeida-Porada G, MullerHW, Zanjani E, Wernet P (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135. doi:10.1084/jem.20040440.
21. Kongkaneramit L, Sarisuta N, Azad N, Lu Y, Iyer AK, Wang L, Rojanasakul Y (2008) Dependence of reactive oxygen species and FLICE inhibitory protein on lipofectamine-induced apoptosis in human lung epithelial cells. J Pharmacol Exp Ther 325:969-977. doi:10.1124/jpet.107.136077.
22. Lakshmipathy U, Pelacho B, Sudo K, Linehan JL, Coucouvanis E, Kaufman DS, Verfaillie CM (2004) Efficient transfection of embryonic and adult stem cells. Stem Cells 22:531-543. doi:10.1634/stemcells.22-4-531.
23. Lam AP, Dean DA (2010) Progress and prospects: nuclear import of nonviral vectors. Gene Ther 7:439-447. doi: 10.1038/gt.2010.31.
24. Lee M, Kim SW (2005) Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res 22:1-10.
25. Lico C, Chen Q, Santi L (2008) Viral vectors for production of recombinant proteins in plants. J Cell Physiol 216:366-377. doi:10.1002/jcp. 21423.
26. Liu YP, Hu YD, Wang F, Ling Y, Kong YZ, Li P (2009) Effect of human telomerase reverse transcriptase gene antisense oligonucleotide on sensitivity of gemcitabine in pancreatic cancer cell. Zhonghua Yi Xue Za Zhi 89:2391-2394.
27. Luo D, Saltzman WM (2000) Synthetic DNA delivery systems. Nat Biotechnol 18:33-37. doi:10.1038/71889.
28. Madeira C, Mendes RD, Ribeiro SC, Boura JS, Aires-Barros MR, da Silva CL, Cabral JM (2010) Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. J Biomed Biotechnol 2010:735-349. doi:10.1155/2010/735349.
29. Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, Muguruma K, Sawada T, OhiraM, Hirakawa K (2010) Role of the stemness factors Sox2, Oct3/4, and Nanog in gastric carcinoma. J Surg Res. doi:10.1016/j.jss.2010.11.903.
30. Maurer N, Fenske DB, Cullis PR (2001) Developments in liposomal drug delivery systems. Expert Opin Biol Ther 1:923-947. doi:10.1517/14712598.1.6.923.
31. Mingozzi F, High KA (2011) Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12:341-355. doi:10.1038/nrg2988.
32. Nabzdyk CS, Chun M, Pradhan L, Logerfo FW (2011) High throughput RNAi assay optimization using adherent cell cytometry. J TranslMed 9:48. doi:10.1186/1479-5876-9-48.
33. Naldini L (2011) Ex vivo gene transfer and correction for cellbased therapies. Nat Rev Genet 12:301-315. doi: 10.1038/nrg2985.
34. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953. doi: 10.1126/science.1164270.
35. Oliveira DM, Goodell MA (2003) Transient RNA interference in hematopoietic progenitors with functional consequences. Genesis 36:203-208. doi:10.1002/gene.10212.
36. Papamichos SI, Kotoula V, TarlatzisBC, Agorastos T, PapazisisK, Lambropoulos AF (2009) OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness. Mol Hum Reprod 15:269-270. doi:10.1093/molehr/gap018.
37. Peister A, Mellad JA, Wang M, Tucker HA, Prockop DJ (2004) Stable transfection of MSCs by electroporation. Gene Ther 11:224-228. doi:10.1038/sj.gt.3302163.
38. Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP, Rainaldi G (2008) The proto-oncogene LRF is under post-transcriptional control ofMiR-20a: implications for senescence. PLoS One 3:e2542. doi:10.1371/journal.pone.0002542.
39. Pouton CW, Seymour LW (2001) Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46:187-203.
40. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, La Russa VF (2005) Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 5:1571-1584. doi: 10.1517/14712598.5. 12.1571.
41. Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1:1458-1461. doi:10.1038/nprot.2006.238.
42. Shafiee A, Kabiri M, Ahmadbeigi N, Yazdani SO, Mojtahed M, Amanpour S, Soleimani M (2011) Nasal septum-derived multipotent progenitors: a potent source for stem cell-based regenerative medicine. Stem Cells Dev 20:2077-2091. doi: 10.1089/scd.2010.0420.
43. Shao L, Wu WS (2010) Gene-delivery systems for iPS cell generation. Expert Opin Biol Ther 10:231-242. doi: 10.1517/14712590903455989.
44. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K (2008) Induced pluripotent stem cells generated without viral integration. Science 322:945-949. doi:10.1126/science.1162494.
45. Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, Parisi S, Russo T (2010) miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. Faseb J 24:3255-3263. doi:10.1096/fj.09-152207.
46. Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, Tuschl T, Schira J, Muller HW, Wernet P (2011) MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One 6:e16138. doi:10.1371/journal.pone.0016138.
47. Van Damme A, Vanden Driessche T, Collen D, Chuah MK (2002) Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2:195-209.
48. Walia B, Satija N, Tripathi RP, Gangenahalli GU (2011) Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine. Stem Cell Rev. doi: 10.1007/s12015-011-9279-x.
49. Weissig V, Torchilin VP (2001) Cationic bolasomes with delocalized charge centers as mitochondriaspecific DNA delivery systems. Adv Drug Deliv Rev 49:127-149.
50. Weissinger F, Reimer P, Waessa T, Buchhofer S, Schertlin T, Kunzmann V, Wilhelm M (2003) Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation. J Lab Clin Med 141:138-149. doi:10.1067/mlc.2003.14.
51. Wolff JA, Budker V (2005) The mechanism of naked DNA uptake and expression. Adv Genet 54:3-20. doi: 10.1016/S0065-2660(05)54001-X.
52. Wright JF (2009) Transient transfection methods for clinical adeno-associated viral vector production. Hum Gene Ther 20:698-706. doi:10.1089/hum.2009.064.
53. Yamano S, Dai J, Moursi AM (2010) Comparison of transfection efficiency of nonviral gene transfer reagents. Mol Biotechnol 46:287-300. doi:10.1007/s12033-010-9302-5.
54. Yamauchi J, Hayashi Y, Kajimoto K, Akita H, Harashima H (2010) Comparison between a multifunctional envelopetype nano device and lipoplex for delivery to the liver. Biol Pharm Bull 33:926-929.
55. Zhang M, Bai CX, Zhang X, Chen J, Mao L, Gao L (2004) Downregulation enhanced green fluorescence protein gene expression by RNA interference in mammalian cells. RNA Biol 1:74-77.